Veliora
A new economy for biomedical research
powered by agentic intelligence.
Structured insights for humans.
Coordinated agent pipelines for end-to-end research.
What Is Veliora
Advancing biomedical research
Synthesize biomedical data into high-quality research reports — combining deep literature mining, rigorous evidence scoring, and end-to-end reproducibility.
How It Works
A research request becomes an economic workflow
The user-facing experience stays simple. The payment and coordination complexity stays in the agent layer.
Step 1
Submit a research request
Choose the disease area, describe the research question, and fund the research job to start the workflow.
Step 2
Specialized agents gather evidence
Specialized agents review the literature, screen candidate molecules, map disease biology, score the strongest leads, and challenge reportable candidates before delivery.
Step 3
Receive a structured research brief
Receive reportable candidates, early-stage hypotheses, or pipeline-reviewed signals with scoring context, key cautions, next-step checks, and a traceable research trail.
Why Arc + Circle Nanopayments
Infrastructure for low-value research payments
Our workflow depends on small paid research steps for data access and evaluation. Arc and Circle make that model practical through gasless payment authorization and batched settlement on Arc.
Per-action research economics
Our workflow breaks research into small paid steps for data access and evaluation. Circle Gateway keeps those low-value actions practical by batching settlement instead of forcing every payment to stand alone onchain.
USDC-native transaction flow
Buyers authorize payments in USDC, and Arc keeps payment and gas logic aligned around the same asset instead of introducing a separate volatile gas token into the workflow.
Fast finality for coordination
Research runs involve many sequential paid actions. Fast finality helps the workflow continue without long pauses between steps.
Data & Intelligence
Built on the leading biomedical databases and research systems
Each analysis is built from traceable scientific sources and specialized research agents that structure evidence into a reviewable output.
Literature
PubMed / MEDLINE
36M+ peer-reviewed papers. Full-text mining, PMID tracing, evidence scoring.
Drug Database
ChEMBL
2.4M+ bioactive compounds. Target binding, mechanism of action, clinical annotations.
Disease Biology
OpenTargets
Disease-target associations and pathway-level target context used to anchor mechanism-first ranking.
Trials
ClinicalTrials.gov
480K+ registered studies. Active trial landscape, eligibility, NCT tracing.
Task-specific research orchestration
Each specialist agent handles a distinct research task, from literature review and compound screening to pathway analysis and structured evaluation.
Agent Pipeline
Dr. Iris
Research OrchestratorReceives the research request, coordinates all downstream agents, manages the USDC payment flow, and submits the final deliverable on-chain.
Dr. Mira
PubMed + OpenAlexMines peer-reviewed papers, extracts evidence scores, clinical maturity, study types, and returns ranked PMIDs with full provenance.
Dr. Rex
ChEMBL + UniProt + OpenTargetsQueries bioactive compound databases for target binding, mechanism of action, and existing clinical annotations for candidate drugs.
Dr. Nova
OpenTargets + ClinicalTrials.govMaps disease-associated targets, aggregates pathway overlap, and adds active trial context to anchor the report in disease biology.
Dr. Spark
Cross-indication SynthesisSynthesizes literature, compound, and disease-biology signals into cross-indication hypotheses while separating likely repurposing leads from disease-native assets.
Dr. Vera
Structured ScoringApplies the fixed 0–100 scoring rubric across literature support, mechanism overlap, clinical evidence, and safety profile, then explains why each candidate ranked where it did.
Dr. Vale
Critical ReviewChallenges reportable candidates with independent counter-arguments when a scored shortlist emerges, focusing on confounders, translational risk, and reasons a lead may not hold up.
Dr. Aria
Final Research BriefGenerates the structured research brief with reportable candidates, early-stage hypotheses, or pipeline-reviewed signals, plus scoring context, provenance, and the required research disclaimer.
Independent Peer Review Panel
Dr. Leo
Methodology ReviewVerifies methodological integrity, provenance coverage, required citations, and overall report completeness before a brief can pass review.
Dr. Zara
Consistency ReviewAudits score consistency, candidate-to-evidence alignment, and cross-field contradictions across the final brief.
Dr. Swift
ArbiterInvoked only on a split decision. Reviews both reviewer rationales and issues the final ruling under a rejection-first standard.
Start Here